Health News
Drug-Mania Lacks Support
As prescriptions for antipsychotic drugs become increasingly common, concerns about their effectiveness are also on the rise.
Scammers Posing as FDA Demanding "Fines"
The FDA has issued a warning to the public about extortion plots in which criminals are impersonating FDA officials over the phone and illegally demanding money from unsuspecting victims.
Potential Salmonella in Toronto-Based Greens
Boncheff Greenhouses, Inc. out of Canada has issued a voluntary recall of cilantro and parsley due to potential Salmonella bacteria, which can cause serious infections.
Alcohol Prep Pads and Swabs Recalled
Over-the-counter manufacturer Triad Group is recalling all lots of alcohol prep pads and swabs due to potential bacterial contamination.
Is Your Antibiotic a Lightweight?
Teva Pharmaceuticals has issued a voluntary recall of antibiotic tablets after finding that some are underweight, meaning patients may not be getting their required dosage.
Early Warning System from the FDA
In response to a nationwide drug shortage that is causing serious morbidity and mortality in the United States and Canada, United States Senator Amy Klobuchar (D-MN) announced that she plans to initiate legislation that would require pharmaceutical companies to notify the Food and Drug Administration (FDA) of impending shortages or cessations in production.
Beating Bacteria at Its Own Game
Researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID) have pinpointed a protein that helps bacteria detach from medical devices and spread in the body.
From Institutions to Independence
U.S. Housing and Urban Development (HUD) Secretary Shaun Donovan and Health and Human Services (HHS) Secretary Kathleen Sebelius have announced a joint venture aiding 1,000 non-elderly, disabled Americans.
Period of Adjustment
Health and Human Services Secretary Kathleen Sebelius sent a letter to Congress outlining progress on the implementation of the Affordable Care Act (ACA).
A New Era of Fungal Infections
The incidence of pulmonary fungal infections is on the rise. In response, the American Thoracic Society (ATS) has issued a new clinical policy statement, replacing guidelines published in 1988, for the treatment of such infections.